Unraveling the dual role of METTL3-mediated m&lt;sup&gt;6&lt;/sup&gt;A RNA modification in bladder cancer: mechanisms, therapeutic vulnerabilities, and clinical implications. The gene discussed is METTL3; the disease is urinary bladder carcinoma.